Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: Protocol for an open-label, parallel-group, superiority, randomized controlled trial
James S.H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew, Pouya Azar
doi: https://doi.org/10.1101/2020.05.22.20106062
James S.H. Wong
1Addictions and Concurrent Disorders Research Group, Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
BScMohammadali Nikoo
1Addictions and Concurrent Disorders Research Group, Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
MDJean N. Westenberg
1Addictions and Concurrent Disorders Research Group, Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
BScJanet G. Suen
1Addictions and Concurrent Disorders Research Group, Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
BScJennifer Wong
1Addictions and Concurrent Disorders Research Group, Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Reinhard M. Krausz
1Addictions and Concurrent Disorders Research Group, Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
MD, PhD, FRCPCChristian G. Schütz
2Behavioral Reward Affect + Impulsivity Neuroscience Lab, Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
MD, PhD, MPH, FRCPCMarc Vogel
3University of Basel Psychiatric Hospital, Division of Addictive Disorders, Wilhelm Klein-Strasse 27, 4002, Basel, Switzerland
PD Dr. med., MScPHJesse A. Sidhu
4Department of Psychiatry, University of British Columbia & Vancouver General Hospital, Vancouver, British Columbia, Canada
MD, MPH, FRCPCJessica Moe
5Department of Emergency Medicine, University of British Columbia & Vancouver General Hospital, Vancouver, British Columbia, Canada
6BC Centre for Disease Control, Provincial Health Services Authority, British Columbia, Canada
MD, FRCPC, DABEM, MSc, MAShane Arishenkoff
7Department of Medicine, University of British Columbia & Vancouver General Hospital, Vancouver, British Columbia, Canada
MD, FRCPCDonald Griesdale
8Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia & Vancouver General Hospital, Vancouver, British Columbia, Canada
MD, MPH, FRCPCNickie Mathew
4Department of Psychiatry, University of British Columbia & Vancouver General Hospital, Vancouver, British Columbia, Canada
9BC Mental Health & Substance Use Services, Provincial Health Services Authority, British Columbia, Canada
MD, MSc, ABPN, FRCPC, ABPMPouya Azar
4Department of Psychiatry, University of British Columbia & Vancouver General Hospital, Vancouver, British Columbia, Canada
MD, FRCPC, Dip. ABAMArticle usage
Posted May 26, 2020.
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: Protocol for an open-label, parallel-group, superiority, randomized controlled trial
James S.H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew, Pouya Azar
medRxiv 2020.05.22.20106062; doi: https://doi.org/10.1101/2020.05.22.20106062
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: Protocol for an open-label, parallel-group, superiority, randomized controlled trial
James S.H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew, Pouya Azar
medRxiv 2020.05.22.20106062; doi: https://doi.org/10.1101/2020.05.22.20106062
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (624)
- Anesthesia (162)
- Cardiovascular Medicine (2335)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11703)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3687)
- Geriatric Medicine (345)
- Health Economics (632)
- Health Informatics (2365)
- Health Policy (925)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3450)
- Nursing (195)
- Nutrition (520)
- Oncology (1802)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (285)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6091)
- Radiology and Imaging (1256)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)